1. A search for an excited muon decaying to a muon and two jets in pp collisions at s=8TeV with the ATLAS detectoratlas.publications@cern.ch. (11th July 2016) Authors: Aad, G; Abbott, B; Abdallah, J; Abdinov, O; Abeloos, B; Aben, R; Abolins, M; AbouZeid, O S; Abramowicz, H; Abreu, H; Abreu, R; Abulaiti, Y; Acharya, B S; Adamczyk, L; Adams, D L; Adelman, J; Adomeit, S; Adye, T; Affolder, A A; Agatonovic-Jovin, T Other Names: collab. Journal: New journal of physics Issue: Volume 18:Number 7(2016:Jul.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adapting and testing a tool to map digital health resources use by older adults in Israel and Taiwan: Diane Levin-Zamir. (25th October 2022) Authors: Levin-Zamir, D; Baron-Epel, O; Chang, P; Neter, E; Eliahu, E; Duong, T Journal: European journal of public health Issue: Volume 32(2022)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Measurement of the τ Michel parameters $\bar{\eta}$ and $\xi\kappa$ in the radiative leptonic decay $\tau^- \rightarrow \ell^- \nu_{\tau} \bar{\nu}_{\ell}\gamma$. (24th February 2018) Authors: Shimizu, N; Aihara, H; Epifanov, D; Adachi, I; Al Said, S; Asner, D M; Aulchenko, V; Aushev, T; Ayad, R; Babu, V; Badhrees, I; Bakich, A M; Bansal, V; Barberio, E; Bhardwaj, V; Bhuyan, B; Biswal, J; Bobrov, A; Bozek, A; Bračko, M Journal: Progress of theoretical and experimental physics Issue: Volume 2018:Number 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Organ Impairment—Drug–Drug Interaction Database: A Tool for Evaluating the Impact of Renal or Hepatic Impairment and Pharmacologic Inhibition on the Systemic Exposure of Drugs. (14th July 2015) Authors: Yeung, CK; Yoshida, K; Kusama, M; Zhang, H; Ragueneau‐Majlessi, I; Argon, S; Li, L; Chang, P; Le, CD; Zhao, P; Zhang, L; Sugiyama, Y; Huang, S‐M Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 4:Number 8(2015:Aug.) Page Start: 489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P3727Astragaloside IV reduces cardiac oxidation and improves left ventricular diastolic dysfunction. (28th August 2018) Authors: Wang, Q; Jeong, E M; Liu, H; Gu, L Z; Xie, A; Liu, M; Lin, X; Sun, S G; Xu, G L; Wu, Q; Chang, P; Dudley, S C; Bai, F; Yu, J Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PS7:133 Exposure-response modelling and exposure-safety modelling analyses in two phase ii studies of atacicept in sle. (21st March 2018) Authors: Papasouliotis, O; Yalkinoglu, O; Vazquez Mateo, C; Wax, S; Kao, A; Chang, P; Fleuranceau-Morel, P; Mahnke, L Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 1 Page Start: A101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. RELIABILITY AND VALIDITY OF CARE FOR OLDER ADULTS IN HOSPITALS AND NURSING FACILITIES IN CHINA. (16th November 2018) Authors: Jiang, L; Jiang, C; Cui, Y; Chang, P Journal: Innovation in aging Issue: Volume 2(2018)Supplement 1 Page Start: 960 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. S7A:4 Reduction of systemic lupus flares by atacicept in a randomised, placebo-controlled, phase iib study (address ii) and its extension study. (21st March 2018) Authors: Wallace, DJ; Isenberg, DA; Kao, A; Vazquez-Mateo, C; Fleuranceau-Morel, P; Chang, P; Merril, JT Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 1 Page Start: A25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. S7A:5 Sri response, attainment of low disease activity and safety in patients with systemic lupus treated with atacicept in a phase iib study (address ii). (21st March 2018) Authors: Merril, JT; Morand, E; Wallace, DJ; Kao, A; Vazquez-Mateo, C; Chang, P; Fleuranceau-Morel, P; Isenberg, DA Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 1 Page Start: A26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SAT0219 Efficacy and safety of atacicept in patients with high disease activity in a 24-week, randomized, placebo-controlled, phase iib study (ADDRESS II). (15th June 2017) Authors: Merrill, JT; Wallace, DJ; Kao, A; Mateo, C Vazquez; Fraser, PA; Chang, P; Isenberg, D Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗